Gyre Therapeutics (GYRE) Enterprise Value (2010 - 2026)
Gyre Therapeutics (GYRE) reported Enterprise Value of -$14.1 million for Q1 2026, down 179.87% year-over-year from $17.7 million in Q1 2025, and down 251.08% on a QoQ basis from -$4.0 million in Q4 2025.
Gyre Therapeutics (GYRE) has 17 years of Enterprise Value data on file, last reported at -$14.1 million in Q1 2026.
- Quarterly Enterprise Value fell 179.87% year-over-year to -$14.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$14.1 million (down 179.87% YoY) and the FY2025 annual result came in at -$4.0 million, down 148.01% from the prior year.
- Enterprise Value declined to -$14.1 million in Q1 2026 per GYRE's latest filing, from -$4.0 million in the prior quarter.
- Across five years, Enterprise Value topped out at $17.7 million in Q1 2025 and bottomed at -$75.4 million in Q2 2022.
- The 5-year median for Enterprise Value is -$4.0 million (2025), against an average of -$8.9 million.
- The widest annual swing landed in 2024, when Enterprise Value jumped 564.95%; it then plunged 340.04% in 2025.
- Tracing GYRE's Enterprise Value over 5 years: stood at $4.5 million in 2022, then sank by 182.57% to -$3.7 million in 2023, then jumped by 324.62% to $8.4 million in 2024, then plunged by 148.01% to -$4.0 million in 2025, then sank by 251.08% to -$14.1 million in 2026.
- Per Business Quant, the three latest GYRE Enterprise Value figures stand at -$14.1 million (Q1 2026), -$4.0 million (Q4 2025), and -$24.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | -14.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.13 Mn |
| Dec 31, 2025 | -4.03 Mn |
| Sep 30, 2025 | -24.55 Mn |
| Jun 30, 2025 | -9.10 Mn |
| Mar 31, 2025 | 17.69 Mn |
| Dec 31, 2024 | 8.38 Mn |
| Sep 30, 2024 | 10.23 Mn |
| Jun 30, 2024 | 7.90 Mn |
| Mar 31, 2024 | 15.85 Mn |
| Dec 31, 2023 | -3.73 Mn |
| Sep 30, 2023 | -2.20 Mn |
| Jun 30, 2023 | -11.53 Mn |
| Mar 31, 2023 | -12.65 Mn |
| Dec 31, 2022 | 4.52 Mn |
| Sep 30, 2022 | -23.10 Mn |
| Jun 30, 2022 | -75.39 Mn |
| Mar 31, 2022 | -34.82 Mn |
| Dec 31, 2021 | -46.85 Mn |
| Sep 30, 2021 | -64.53 Mn |
| Jun 30, 2021 | -86.52 Mn |
| Mar 31, 2021 | -130.96 Mn |
| Dec 31, 2020 | -130.89 Mn |
| Sep 30, 2020 | -102.88 Mn |
| Jun 30, 2020 | -117.36 Mn |
| Mar 31, 2020 | -104.53 Mn |
| Dec 31, 2019 | -138.36 Mn |
| Sep 30, 2019 | -146.93 Mn |
| Jun 30, 2019 | -93.94 Mn |
| Mar 31, 2019 | -25.07 Mn |
| Dec 31, 2018 | -119.10 Mn |
| Sep 30, 2018 | -36.05 Mn |
| Jun 30, 2018 | -46.71 Mn |
| Mar 31, 2018 | -126.73 Mn |
| Dec 31, 2017 | -42.97 Mn |
| Sep 30, 2017 | -16.70 Mn |
| Jun 30, 2017 | -38.39 Mn |
| Mar 31, 2017 | -27.39 Mn |
| Dec 31, 2016 | -29.73 Mn |
| Sep 30, 2016 | -19.53 Mn |
| Jun 30, 2016 | -23.95 Mn |
| Mar 31, 2016 | -27.67 Mn |
| Dec 31, 2015 | -32.50 Mn |
| Sep 30, 2015 | -36.76 Mn |
| Jun 30, 2015 | -23.88 Mn |
| Mar 31, 2015 | -33.72 Mn |
| Dec 31, 2014 | -1.82 Mn |
| Sep 30, 2014 | -55.81 Mn |
| Jun 30, 2014 | -97.72 Mn |
| Mar 31, 2014 | -97.25 Mn |
| Dec 31, 2013 | -40.67 Mn |
| Sep 30, 2013 | -96.76 Mn |
| Jun 30, 2013 | -100.20 Mn |
| Mar 31, 2013 | -109.84 Mn |
| Dec 31, 2012 | -46.12 Mn |
| Sep 30, 2012 | -143.70 Mn |
| Jun 30, 2012 | -156.48 Mn |
| Mar 31, 2012 | -176.56 Mn |
| Dec 31, 2011 | -195.00 Mn |
| Sep 30, 2011 | -213.48 Mn |
| Jun 30, 2011 | -233.18 Mn |
| Mar 31, 2011 | -138.84 Mn |
| Dec 31, 2010 | -214.02 Mn |
| Sep 30, 2010 | -185.80 Mn |
| Jun 30, 2010 | -221.63 Mn |